Stock listing

OTC:RBSH Rebus Hldgs Inc. Stock

Follow Rebus Hldgs Inc. into a list and get an email when it puts out news.

Share price · OTC:RBSH

$0.0001 USD 0.0000 (0.0%)

Close on Oct 15, 2026 · Data provided by Twelve Data

Ticker: OTC:RBSH
Asset type: Stock
Exchange: OTC
Currency: USD

Latest news

Inspyr Therapeutics Announces Research Collaboration with the National Institutes of Health

Oct 23, 2017

Inspyr Therapeutics Announces Research Collaboration with NYU Winthrop Hospital

Oct 4, 2017

Inspyr Therapeutics Announces Research Collaboration with University of Virginia School of Medicine

Oct 2, 2017

Inspyr Therapeutics and Lewis and Clark Pharmaceuticals Complete Merger

Sep 13, 2017

Inspyr Therapeutics Announces Private Placement of Senior Convertible Debentures

Sep 12, 2017

Inspyr Therapeutics and Lewis and Clark Pharmaceuticals to Merge

May 30, 2017

Inspyr Therapeutics Signs Commitment Letter with Milost Global

Mar 28, 2017

Inspyr Therapeutics Secures a $100 Million Financing Agreement from Milost Global

Mar 17, 2017

Inspyr Therapeutics Appoints NIH Veterans to Lead New Translational Medicine Initiatives and Pipeline Expansion

Mar 6, 2017

Inspyr Therapeutics Initiates Mipsagargin Combination Therapy Program for Gastric Cancer

Feb 22, 2017

All Rebus Hldgs Inc. news

Rebus Hldgs Inc. on 6ix

News releases: 48 in all · newest Oct 23, 2017 · oldest 2015

Log in to ask 6ix AI your own questions about Rebus Hldgs Inc.